Jason Highsmith
Medical Device & Capital Equipment Sales Rep / 4X President’s Club Winner / #1 US Sales Rank 2022 & 2023 / New Product Launches / Territory Turnaround Specialist / Hospital & IDN Account Conversions
- Role
- Regional Clinical Oncology Specialist- Gi at Natera
- Location
- Tampa, FL, US
- LinkedIn followers
- 500 followers
About Jason Highsmith
My success as a top-performing medical device & capital equipment sales rep can be demonstrated by winning 4 President’s Club Awards and earning several Top US rankings over the years with Ambu Medical, Envizion, Avanos, Veran Medical, and Boston Scientific. I’ve been successful in multiple markets including hospitals/IDNs, oncology, pulmonology, thoracic surgeons, radiation oncologists, general surgery, interventional radiology, gastroenterology, allergy, ENT, pain management, emergency medicine, and ICU. My ability to exceed expectations in any market can be demonstrated by recent results:• Turned around a Florida territory, selling $1.2 million and converting several hospital accounts in FY 2024.• #5 in US for converting the highest number of customers to a specific medical device in FY 2024.• #1 in US (2022 & YTD 2023), generating 237% of new account growth quota. These results have been based on my strengths for building relationships with physicians & surgeons; converting accounts from major competitors; selling/educating physicians on product benefits; penetrating new hospital and medical facility accounts; negotiating/closing large deals with key decision-makers; and conducting in-services on medical devices/implants, capital equipment, and innovative diagnostic systems.
Experience
Regional Clinical Oncology Specialist- Gi
Oct 2025 — Present · FL, US
Signatera is a personalized, tumor-informed circulating tumor DNA (ctDNA) blood test developed by Natera to detect molecular residual disease (MRD) and monitor cancer recurrence across multiple solid tumors, including colorectal, breast, lung, and other cancers. By performing a one-time analysis of a patient’s tumor tissue and normal DNA, Signatera creates a custom assay that tracks tumor-specific mutations in subsequent blood draws—providing highly sensitive, real-time insights into treatment response and early detection of relapse without invasive procedures.
Education
University of South Florida
BS, Business / Marketing
2000 — 2004
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.